Backing Toothfairy Again: £7.3M to Transform Access to Dental Care
At Haatch, we first invested in Toothfairy back in 2021. Even then, it was clear that Deepak and Kian had the ambition, credibility and vision to tackle one of the UK’s biggest and most underserved challenges: access to dental care.
Fast forward to today, and we’re proud to back them again as they announce a new £7.3 million investment round, led by LBO France. This milestone is a testament to how far the business has come, and to the impact it is already having on millions of people across the UK.
We’re also delighted to be co-investing alongside CRB Health, Portfolio Ventures, Slingshot and ADA Ventures, a strong group of partners who share our conviction in Toothfairy’s potential to redefine how people access dental care.
Since our first investment, the team has built remarkable momentum. Toothfairy is now the world’s first CQC and MHRA approved virtual dental platform, with over 3 million members and more than 100,000 patients treated. They’ve achieved £2.6m revenue in 2024 while remaining capital efficient, secured retail partnerships with Tesco, Superdrug and Lloyds Pharmacy, and won “App of the Year” as well as being named one of Sifted’s Top 100 Fastest Growing Companies in the UK.
The UK is facing an urgent dental crisis, with millions unable to access affordable and timely treatment. Toothfairy’s solution is digital first, patient focused and clinically credible, combining AI-driven tools, remote consultations and partnerships with major employers and insurers. It’s exactly the kind of bold, category-defining business we set out to back.
With this new round, the team will expand clinical services, deepen their AI technology, and grow their partnerships to reach even more people. We couldn’t be more excited to continue this journey with them.
At Haatch, we don’t back many companies, but when we do, we back them with conviction. Toothfairy is one of those companies.
The latest
from Haatch
‘Capital Growth’ Has Many Meanings. So does ‘Performance’!
Why do we invest? The glib answer is ‘to make money’. For most investors however, I suspect the reasons are much more nuanced.
When I first committed funds to a Haatch portfolio company, the reasons for doing so were multiple. Of course, I was looking forward to value amplification and the tax basis was also highly attractive. However, I also had a strong sense of wanting to ‘plug in’ to a modern, cutting-edge area of technology.
Headcount Is Dead as a Growth Metric. Here's What Our Portfolio Data Says Replaced It.
For two decades, venture capital used a crude proxy for progress: how many people have you hired? Team size signalled ambition, traction, momentum. If a seed-stage company doubled headcount, it was "scaling."Our portfolio data now tells us that era is over.Across roughly 200 early-stage B2B software companies we track, median revenue growth over the past two years ran at around 50% annualized. Median headcount growth over the same period? Zero.
